The present study was designed to assess whether competitive athletes and non-athletes differ in terms of certain personality traits linked to atypicalities in emotion awareness and regulation, and whether being an athlete accounts for unique variance in symptoms of anxiety and depression when these traits and exposure to childhood emotional abuse are held constant. In order to address these questions, we had 483 undergraduates (M = 19.7 years; 75.8% female), including 228 athletes and 255 non-athletes, complete self-report measures of personality (alexithymia, sensory processing sensitivity or SPS, and anxiety sensitivity or AS), exposure to emotional abuse in childhood, pandemic-related stress, anxiety, and depression. Recreational and elite athletes scored lower on SPS and depression than non-athletes, and recreational athletes also scored lower than non-athletes on AS. However, involvement in competitive sport did not predict depression or anxiety when other variables were controlled for. Alexithymia, AS, and childhood emotional abuse predicted depression, and SPS, AS, and childhood emotional abuse predicted anxiety. The same pattern was seen in a subgroup of athletes (n = 91) who had recently been coached, except that in this subgroup exposure to emotionally abusive coaching was found to be an additional risk factor for anxiety. These findings help to disentangle general and sport-specific risk factors for anxiety and depression and may have important implications for preventing and treating these problems in athletes and non-athletes alike.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.psychsport.2024.102773 | DOI Listing |
BMC Psychiatry
December 2024
Department of Psychiatry, St. Paul's Hospital Millennium Medical College, Addis Ababa, Addis Ababa, Ethiopia.
Background: Problematic Internet use (PIU) is a growing concern in modern society. There is a limitation of epidemiologic data related to PIU. This is due to a lack of consensus on the definition and variability of assessment tools of PIU.
View Article and Find Full Text PDFBMC Psychiatry
December 2024
Social Development & Health Promotion Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Background: Anxiety during pregnancy is linked to adverse maternal and neonatal outcomes, as well as dissatisfaction with childbirth, and may contribute to the development of postpartum depression. This study aimed to evaluate the effect of mindfulness-based counselling on the anxiety levels and childbirth satisfaction among primiparous pregnant women.
Methods: This two-group, parallel, randomized controlled trial involved 60 eligible primiparous pregnant women who were referred to health centers in Kermanshah province (western Iran).
J Voice
December 2024
Department of Surgery, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium; Division of Laryngology and Bronchoesophagology, Department of Otolaryngology Head Neck Surgery, EpiCURA Hospital, Baudour, Saint-Ghislain, Belgium; Department of Otolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France; Department of Otolaryngology, Elsan Hospital, Paris, France. Electronic address:
Objective: To investigate the anxiety and depression features in laryngopharyngeal reflux disease (LPRD).
Methods: A laryngologist and librarian conducted a PubMed, Scopus, and Cochrane Library systematic review related to anxiety, depression, and mental health in LPRD through the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statements.
Results: Of the 96 identified studies, 22 publications met the inclusion criteria, accounting for 2162 patients with suspected LPRD (n = 1607), gastroesophageal reflux disease (GERD; n = 423), both LPRD and GERD (n = 132), and 926 healthy/asymptomatic individuals.
BMJ Support Palliat Care
December 2024
Section of Palliative Medicine, Department of Oncology, Rigshospitalet, Kobenhavn, Denmark
Background: Cystic fibrosis (CF) is an incurable, progressive disease that affects multiple organs, causing burdensome symptoms. This study aimed to explore the palliative care needs in patients with CF, focusing on health-related quality of life (HRQOL), fatigue, anxiety and depression.
Methods: From October 2019 to March 2020, a cross-sectional questionnaire survey was conducted with outpatients with CF at the Infectious Medicine Clinic in a Danish University Hospital.
BMJ Open
December 2024
Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, New South Wales, Australia.
Introduction: Sciatica is a debilitating condition that often becomes chronic, and for which there are few effective treatment options. Treatments such as the anti-depressant duloxetine have shown promise, but the evidence is inconclusive. We are describing a high quality, definitive trial to investigate the efficacy, safety and cost-effectiveness of duloxetine in chronic sciatica.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!